Company / PP&E (Net)
Entrada Therapeutics, Inc. PP&E (Net) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$7.3M
FY2025
5-year range
$7.3M / $11.2M
FY2023-FY2025
Trend
-33.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $11M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2025.
Declined from $11M to $7M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, pp&e (net) decreased 33.1% year-over-year.
Company context
Key Data Points
- Altman Z-Score -2.03 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.3M | -33.1% |
| FY2024 | $10.9M | -2.4% |
| FY2023 | $11.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026